CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C18104 | BRD-K49148689 | BRD-K49148689 | -- | -- | -- | Details |
| C18105 | BRD-K49148914 | BRD-K49148914 | -- | -- | -- | Details |
| C18106 | BRD-K49156662 | BRD-K49156662 | -- | -- | -- | Details |
| C18107 | BRD-K49158673 | BRD-K49158673 | -- | -- | -- | Details |
| C18108 | BRD-K49159670 | BRD-K49159670 | -- | -- | -- | Details |
| C18109 | BRD-K49164596 | BRD-K49164596 | -- | -- | -- | Details |
| C18110 | BRD-K49166646 | BRD-K49166646 | -- | -- | -- | Details |
| C18111 | BRD-K49172498 | BRD-K49172498 | -- | -- | -- | Details |
| C18112 | BRD-K49178877 | BRD-K49178877 | -- | -- | -- | Details |
| C18113 | BRD-K49180909 | BRD-K49180909 | -- | -- | -- | Details |
| C18114 | BRD-K49181186 | EMF-sumo1-7 | -- | -- | -- | Details |
| C18115 | BRD-K49183052 | VU-0415113-1 | -- | -- | -- | Details |
| C18116 | BRD-K49183852 | BRD-K49183852 | -- | -- | -- | Details |
| C18117 | BRD-K49184477 | BRD-K49184477 | -- | -- | -- | Details |
| C18118 | BRD-K49203165 | BRD-K49203165 | -- | -- | -- | Details |
| C18119 | BRD-K49207204 | BRD-K49207204 | -- | -- | -- | Details |
| C18120 | BRD-K49208610 | BRD-K49208610 | -- | -- | -- | Details |
| C18121 | BRD-K49211735 | BRD-K49211735 | -- | -- | -- | Details |
| C18122 | BRD-K49215099 | BRD-K49215099 | -- | -- | -- | Details |
| C18123 | BRD-K49215523 | GSK-2636771 | -- | -- | -- | Details |
| C18124 | BRD-K49215584 | BRD-K49215584 | -- | -- | -- | Details |
| C18125 | BRD-K49229349 | vincristine | TUBB | Tubulin inhibitor | -- | Details |
| C18126 | BRD-K49236613 | BRD-K49236613 | -- | -- | 6-iodo-nordihydrocapsaicin | Details |
| C18127 | BRD-K49237419 | KU-C103671 | -- | -- | -- | Details |
| C18128 | BRD-K49255961 | BRD-K49255961 | -- | -- | -- | Details |
| C18129 | BRD-K49258369 | BRD-K49258369 | -- | -- | -- | Details |
| C18130 | BRD-K49258689 | BRD-K49258689 | -- | -- | -- | Details |
| C18131 | BRD-K49262771 | methyl-carbamate | -- | -- | -- | Details |
| C18132 | BRD-K49276305 | BRD-K49276305 | -- | -- | -- | Details |
| C18133 | BRD-K49282125 | BRD-K49282125 | -- | -- | -- | Details |
| C18134 | BRD-K49283005 | BRD-K49283005 | -- | -- | -- | Details |
| C18135 | BRD-K49283955 | BRD-K49283955 | -- | -- | -- | Details |
| C18136 | BRD-K49290616 | BRD-K49290616 | -- | -- | -- | Details |
| C18137 | BRD-K49292348 | BRD-K49292348 | -- | -- | -- | Details |
| C18138 | BRD-K49294047 | BRD-K49294047 | -- | -- | -- | Details |
| C18139 | BRD-K49294207 | BIBU-1361 | EGFR | EGFR inhibitor | -- | Details |
| C18140 | BRD-K49298555 | BRD-K49298555 | -- | -- | -- | Details |
| C18141 | BRD-K49299173 | BRD-K49299173 | -- | -- | -- | Details |
| C18142 | BRD-K49303291 | BRD-K49303291 | -- | -- | -- | Details |
| C18143 | BRD-K49307935 | BRD-K49307935 | -- | -- | -- | Details |
| C18144 | BRD-K49309964 | BRD-K49309964 | -- | -- | -- | Details |
| C18145 | BRD-K49313348 | BRD-K49313348 | -- | -- | -- | Details |
| C18146 | BRD-K49322988 | BRD-K49322988 | -- | -- | -- | Details |
| C18147 | BRD-K49325049 | BRD-K49325049 | -- | -- | -- | Details |
| C18148 | BRD-K49327517 | THZ-2-98-01 | -- | -- | -- | Details |
| C18149 | BRD-K49328571 | dasatinib | EPHA2; ABL1; FYN; KIT; LCK; LYN; PDGFRB; BCR; SRC; YES1 | KIT inhibitor; Src inhibitor; PDGFR inhibitor; Ephrin inhibitor; Abl kinase inhibitor; Tyrosine kinase inhibitor | -- | Details |
| C18150 | BRD-K49328983 | BRD-K49328983 | -- | -- | -- | Details |
| C18151 | BRD-K49330073 | BRD-K49330073 | -- | -- | -- | Details |
| C18152 | BRD-K49333142 | BRD-K49333142 | -- | -- | -- | Details |
| C18153 | BRD-K49333293 | BRD-K49333293 | -- | -- | -- | Details |
| C18154 | BRD-K49335566 | BRD-K49335566 | -- | -- | -- | Details |
| C18155 | BRD-K49338297 | BRD-K49338297 | -- | -- | -- | Details |
| C18156 | BRD-K49345010 | BRD-K49345010 | -- | -- | -- | Details |
| C18157 | BRD-K49345388 | BRD-K49345388 | -- | -- | -- | Details |
| C18158 | BRD-K49350383 | thioguanine | IMPDH1; IMPDH2 | Purine antagonist | -- | Details |
| C18159 | BRD-K49354529 | BRD-K49354529 | -- | -- | -- | Details |
| C18160 | BRD-K49367140 | BRD-K49367140 | -- | -- | -- | Details |
| C18161 | BRD-K49368687 | BRD-K49368687 | -- | -- | -- | Details |
| C18162 | BRD-K49371609 | PIK-75 | PIK3CA | PI3K inhibitor; DNA protein kinase inhibitor | -- | Details |
| C18163 | BRD-K49372556 | mofezolac | -- | -- | -- | Details |
| C18164 | BRD-K49373277 | BRD-K49373277 | -- | -- | -- | Details |
| C18165 | BRD-K49375456 | BRD-K49375456 | -- | -- | -- | Details |
| C18166 | BRD-K49377740 | BRD-K49377740 | -- | -- | -- | Details |
| C18167 | BRD-K49378999 | BRD-K49378999 | -- | -- | -- | Details |
| C18168 | BRD-K49383373 | BRD-K49383373 | -- | -- | -- | Details |
| C18169 | BRD-K49384696 | lincomycin | -- | -- | -- | Details |
| C18170 | BRD-K49384706 | BRD-K49384706 | -- | -- | -- | Details |
| C18171 | BRD-K49391713 | BRD-K49391713 | -- | -- | -- | Details |
| C18172 | BRD-K49401787 | BRD-K49401787 | -- | -- | -- | Details |
| C18173 | BRD-K49403449 | BRD-K49403449 | -- | -- | -- | Details |
| C18174 | BRD-K49404994 | levetiracetam | CACNA1B; SV2A | Calcium channel blocker | -- | Details |
| C18175 | BRD-K49409924 | BRD-K49409924 | -- | -- | -- | Details |
| C18176 | BRD-K49409947 | BRD-K49409947 | -- | -- | -- | Details |
| C18177 | BRD-K49415484 | BRD-K49415484 | -- | -- | -- | Details |
| C18178 | BRD-K49417484 | BRD-K49417484 | -- | -- | -- | Details |
| C18179 | BRD-K49419779 | BRD-K49419779 | -- | -- | -- | Details |
| C18180 | BRD-K49424866 | BRD-K49424866 | -- | -- | -- | Details |
| C18181 | BRD-K49430514 | BRD-K49430514 | -- | -- | -- | Details |
| C18182 | BRD-K49434056 | BRD-K49434056 | -- | -- | -- | Details |
| C18183 | BRD-K49434474 | BRD-K49434474 | -- | -- | -- | Details |
| C18184 | BRD-K49441594 | BRD-K49441594 | -- | -- | -- | Details |
| C18185 | BRD-K49443464 | BRD-K49443464 | -- | -- | -- | Details |
| C18186 | BRD-K49448285 | BRD-K49448285 | -- | -- | bisindolylmaleimide | Details |
| C18187 | BRD-K49452151 | SA-1480001 | -- | -- | -- | Details |
| C18188 | BRD-K49456190 | prima-1-met | TP53 | Thioredoxin inhibitor | -- | Details |
| C18189 | BRD-K49456274 | pilaralisib | -- | -- | -- | Details |
| C18190 | BRD-K49457424 | BRD-K49457424 | -- | -- | -- | Details |
| C18191 | BRD-K49460772 | BRD-K49460772 | -- | -- | -- | Details |
| C18192 | BRD-K49461735 | BRD-K49461735 | -- | -- | -- | Details |
| C18193 | BRD-K49467822 | BRD-K49467822 | -- | -- | -- | Details |
| C18194 | BRD-K49468759 | KIN001-266 | -- | -- | KIN-001-266 | Details |
| C18195 | BRD-K49472569 | BRD-K49472569 | -- | -- | -- | Details |
| C18196 | BRD-K49473389 | BRD-K49473389 | -- | -- | -- | Details |
| C18197 | BRD-K49473928 | BRD-K49473928 | -- | -- | -- | Details |
| C18198 | BRD-K49477212 | BRD-K49477212 | -- | -- | -- | Details |
| C18199 | BRD-K49477330 | BRD-K49477330 | -- | -- | -- | Details |
| C18200 | BRD-K49480198 | BRD-K49480198 | -- | -- | -- | Details |
| C18201 | BRD-K49481516 | galantamine | ACHE; BCHE | Acetylcholinesterase inhibitor | -- | Details |
| C18202 | BRD-K49482378 | BRD-K49482378 | -- | -- | -- | Details |
| C18203 | BRD-K49483184 | BRD-K49483184 | -- | -- | -- | Details |